| Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ... Annals of Oncology 29, iv51-iv67, 2018 | 1018 | 2018 |
| Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ... Annals of Oncology 29, iv68-iv78, 2018 | 982* | 2018 |
| The clinical approach towards chondrosarcoma H Gelderblom, PCW Hogendoorn, SD Dijkstra, CS Van Rijswijk, AD Krol, ... The oncologist 13 (3), 320-329, 2008 | 886 | 2008 |
| Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ... Annals of Oncology 32 (11), 1348-1365, 2021 | 697 | 2021 |
| Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome TC Pansuriya, R van Eijk, P d'Adamo, MAJH van Ruler, ML Kuijjer, ... Nature genetics 43 (12), 1256-1261, 2011 | 600 | 2011 |
| Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, S Bielack, N Abecassis, HT Aro, S Bauer, R Biagini, ... Annals of Oncology 29, iv79-iv95, 2018 | 596 | 2018 |
| Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA VL Luks, N Kamitaki, MP Vivero, W Uller, R Rab, JVMG Bovée, KL Rialon, ... The Journal of pediatrics 166 (4), 1048-1054. e5, 2015 | 583 | 2015 |
| NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In … S Bonvalot, PL Rutkowski, J Thariat, S Carrère, A Ducassou, MP Sunyach, ... The Lancet Oncology 20 (8), 1148-1159, 2019 | 425 | 2019 |
| Multiple osteochondromas JVMG Bovée Orphanet journal of rare diseases 3, 1-7, 2008 | 400 | 2008 |
| Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, JY Blay, N Abecassis, J Bajpai, S Bauer, R Biagini, S Bielack, ... Annals of oncology 33 (1), 20-33, 2022 | 383 | 2022 |
| Identification of a novel, recurrent HEY1‐NCOA2 fusion in mesenchymal chondrosarcoma based on a genome‐wide screen of exon‐level expression data L Wang, T Motoi, R Khanin, A Olshen, F Mertens, J Bridge, PD Cin, ... Genes, Chromosomes and Cancer 51 (2), 127-139, 2012 | 343 | 2012 |
| Cartilage tumours and bone development: molecular pathology and possible therapeutic targets JVMG Bovée, PCW Hogendoorn, JS Wunder, BA Alman Nature Reviews Cancer 10 (7), 481-488, 2010 | 308 | 2010 |
| The clinical approach toward giant cell tumor of bone L Van der Heijden, PDS Dijkstra, MAJ van de Sande, JR Kroep, RA Nout, ... The oncologist 19 (5), 550-561, 2014 | 291 | 2014 |
| Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up SJ Strauss, AM Frezza, N Abecassis, J Bajpai, S Bauer, R Biagini, ... Annals of Oncology 32 (12), 1520-1536, 2021 | 289 | 2021 |
| Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array RC Slieker, SD Bos, JJ Goeman, JVMG Bovée, RP Talens, ... Epigenetics & chromatin 6, 1-12, 2013 | 270 | 2013 |
| Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients SHM Verdegaal, JVMG Bovée, TC Pansuriya, RJ Grimer, H Ozger, ... The oncologist 16 (12), 1771-1779, 2011 | 245 | 2011 |
| Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment JVMG Bovée, AM Cleton-Jansen, AHM Taminiau, PCW Hogendoorn The lancet oncology 6 (8), 599-607, 2005 | 244 | 2005 |
| Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors D Eefting, YM Schrage, MJA Geirnaerdt, S Le Cessie, AHM Taminiau, ... The American journal of surgical pathology 33 (1), 50-57, 2009 | 231 | 2009 |
| EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas JVMG Bovée, AM Cleton-Jansen, W Wuyts, G Caethoven, AHM Taminiau, ... The American Journal of Human Genetics 65 (3), 689-698, 1999 | 227 | 1999 |
| Enchondromatosis: insights on the different subtypes TC Pansuriya, HM Kroon, JVMG Bovée International journal of clinical and experimental pathology 3 (6), 557, 2010 | 223 | 2010 |
